Drugs / Lornoxicam
Lornoxicam
Trials 7
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 23 trials | ||||||
| Phase 2 | NCT01117948 | Sep 2009 → Apr 2011 | Alzheimer disease | JSW Lifesciences | Terminated | No outcome recorded |
| Phase 2 | NCT00293657 | Dec 2005 → Apr 2006 | migraine disorder | POZEN | Completed | No outcome recorded |
| Phase 2 | NCT00293631 | Nov 2005 → Mar 2006 | — | POZEN | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT02750917 | Sep 2014 → Jan 2015 | — | Foisor Orthopedics Clinical Hospital | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT01564680 | Mar 2009 → Mar 2011 | — | Imam Abdulrahman Bin Faisal University | Completed | No outcome recorded |
| Phase 4 | NCT00997750 | Mar 2007 → Dec 2008 | acute coronary syndrome | Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01055470 | Dec 2008 → Jun 2009 | osteoarthritis, knee | Government Medical College, Bhavnagar | Completed | No outcome recorded |
| Comparator or background therapy9 trials | ||||||
| Phase 1/2 | NCT01718756 Comparator | Jun 2013 → Dec 2021 | — | Mansoura University | Suspended | No outcome recorded Stop: Business |
| Phase 2 | NCT01480752 Comparator | Sep 2011 → Sep 2012 | acute apical periodontitis | Islamic Azad University, Sanandaj | Completed | No outcome recorded |
| Phase 3 | NCT01069055 Comparator | Feb → Jun 2010 | — | Diskapi Teaching and Research Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT05679453 Comparator | Jul → Sep 2022 | — | Kutahya Health Sciences University | Completed | No outcome recorded |
| Phase 4 | NCT03038321 Comparator | Feb → Dec 2017 | cystitis, non-invasive bladder urothelial carcinoma | Mansoura University | Unknown | No outcome recorded |
| — | NCT07493226 Comparator | Apr 2026 → Feb 2027 expected | frozen shoulder, neuropathy, painful | Konya Beyhekim Training and Research Hospital | Recruiting | No outcome recorded |
| — | NCT03780556 Comparator | Jan 2016 → Jul 2017 | urinary tract obstruction | Ain Shams University | Completed | No outcome recorded |
| — | NCT02025166 Comparator | Jan 2014 → Jan 2015 | — | Rambam Health Care Campus | Unknown | No outcome recorded |
| — | NCT01638962 Comparator | Aug 2012 → Aug 2015 | osteoarthritis, knee | University of Southern Denmark | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 17 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | lornoxicam | “The "continuous infusion" group received 20-mL i.v. boluses of lornoxicam 0.8 mg/mL starting 20 min before induction of anaesthesia followed by a 12 hourly 20-mL i.v. boluses...” NCT01718756 ↗15“Patients randomized into this group (n=40) will, again by simple randomization, be given oral tablets of meloxicam or lornoxicam” NCT07493226 ↗ “lornoxicam 8 mg, 6 hours after IVI of BCG and continue for another 2 days post instillation.” NCT03038321 ↗ “Lornoxicam” NCT01638962 ↗ |
| Known as | Lorcam | ChEMBL registry synonym — accepted as the source's own label CHEMBL1569487 ↗ |
| Known as | Lornoxicam: Xefo | “Lornoxicam: Xefo” NCT01069055 ↗ |
| Known as | NSC-759620 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1569487 ↗ |
| Known as | RO 13-9297 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1569487 ↗ |
| Known as | Xefo | “(Xefo ''lornoxicam 8 mg'') [Multi-Apex - Egypt, under license of: NYCOMED, Austria]” NCT03038321 ↗ |
| Action | Inhibit | “Lornoxicam, nonselective COX-inhibitor” NCT00997750 ↗ |
| Modality | Small molecule | “Lornoxicam is a member of the NSAID class of anti-inflammatory drugs” NCT00293657 ↗ |
| Route | Intravenous | “single dose of intravenous lornoxicam” NCT00293631 ↗ |